Skip to main content
. Author manuscript; available in PMC: 2010 Aug 3.
Published in final edited form as: J Immunol. 2009 Jul 27;183(4):2585–2592. doi: 10.4049/jimmunol.0803660

FIGURE 5.

FIGURE 5

Transitional 1 and non-B cells produce MMP9 in response to LPS treatment. a, CD23 surface expression was determined by flow cytometry 24 h after LPS treatment of the indicated B cell populations. b, Culture supernatants from LPS treated (filled line) or nontreated (solid line) C57BL/6 isolated splenic populations (shown on top of the histograms) were assayed for CD23 cleaving activity as in Fig. 4. Shown are histograms of supernatant treated MyD88−/− B cells. c, LPS-treated culture supernatants from the indicated isolated populations were assayed as in Fig. 4 and data presented as mean CD23 expression by supernatant treated MyD88−/− B cells.